Optiscan Imaging Ltd (ASX: OIL) is a frontrunner in digital microscopic imaging, with its innovative solutions touted as being available "in the palm of your hand." Utilizing their proprietary endomicroscopic technology, Optiscan Imaging delivers real-time, 3D in vivo imaging at the single-cell level, a breakthrough for medical, translational, and pre-clinical applications.
Founded in 1994 and headquartered in Australia, the company has established itself within the Health Care industry as a pivotal player offering clinicians tools to make immediate, informed decisions. This technology facilitates earlier disease detection and management, potentially enhancing patient outcomes and optimizing healthcare costs.
Their last known financial activity was an $8.00M Post-IPO Debt investment in January 2013. With a well-established market presence, Optiscan Imaging remains committed to revolutionizing healthcare with its cutting-edge imaging solutions.